Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 2 |
| Since 2017 (last 10 years) | 3 |
| Since 2007 (last 20 years) | 3 |
Descriptor
| Data Analysis | 3 |
| Medical Research | 3 |
| Research Problems | 3 |
| Intervention | 2 |
| Meta Analysis | 2 |
| Accuracy | 1 |
| Bias | 1 |
| Comparative Analysis | 1 |
| Consortia | 1 |
| Corporations | 1 |
| Correlation | 1 |
| More ▼ | |
Author
Publication Type
| Journal Articles | 3 |
| Information Analyses | 2 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Prathiba Natesan Batley; Erica B. McClure; Brandy Brewer; Ateka A. Contractor; Nicholas John Batley; Larry Vernon Hedges; Stephanie Chin – Grantee Submission, 2023
N-of-1 trials, a special case of Single Case Experimental Designs (SCEDs), are prominent in clinical medical research and specifically psychiatry due to the growing significance of precision/personalized medicine. It is imperative that these clinical trials be conducted, and their data analyzed, using the highest standards to guard against threats…
Descriptors: Medical Research, Research Design, Data Analysis, Effect Size
Rioux, Charlie; Little, Todd D. – International Journal of Behavioral Development, 2021
Missing data are ubiquitous in studies examining preventive interventions. This missing data need to be handled appropriately for data analyses to yield unbiased results. After a brief discussion of missing data mechanisms, inappropriate missing data treatments and appropriate missing data treatments, we review the current state of missing data…
Descriptors: Prevention, Intervention, Data Analysis, Correlation
Nejstgaard, Camilla Hansen; Lundh, Andreas; Abdi, Suhayb; Clayton, Gemma; Gelle, Mustafe Hassan Adan; Laursen, David Ruben Teindl; Olorisade, Babatunde Kazeem; Savovic, Jelena; Hróbjartsson, Asbjørn – Research Synthesis Methods, 2022
Randomised trials are often funded by commercial companies and methodological studies support a widely held suspicion that commercial funding may influence trial results and conclusions. However, these studies often have a risk of confounding and reporting bias. The risk of confounding is markedly reduced in meta-epidemiological studies that…
Descriptors: Medical Research, Randomized Controlled Trials, Corporations, Financial Support

Peer reviewed
Direct link
